The therapeutic potential of rutin for diabetes: An update

Mini-Reviews in Medicinal Chemistry

Volumn 15, Issue 7, 2015, Pages 524-528

  Habtemariam, Solomon ^a   Lentini, Giovanni ^b  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Anti inflammatory; Antioxidant; Diabetes; Multifunctional compound; Organ protection; Rutin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CHOLESTEROL; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN RECEPTOR SUBSTRATE; INSULIN RECEPTOR SUBSTRATE 2; LAMININ; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; REACTIVE OXYGEN METABOLITE; RUTOSIDE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL; ANTIDIABETIC AGENT;

ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; DIABETES MELLITUS; DOWN REGULATION; GLUCOSE TRANSPORT; HUMAN; LIPID METABOLISM; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; CHEMICAL STRUCTURE; CHEMISTRY;

DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; MOLECULAR STRUCTURE; RUTIN;

EID: 84929306925     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/138955751507150424103721     Document Type: Article

References (63)

1. Diabetes: Fact sheet No.312. http://www.who.int/mediacentre/ factsheets/fs312/en/index.html (Accessed October 31, 2014).
2. Whitingc, D.R.; Guariguata, L.; Weil, C.; Shaw, J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diab. Res. Clin. Pract., 2011, 94, 311-321.
3. Habtemariam, S.; Varghese, G.K. The Antidiabetic Therapeutic Potential of Dietary Polyphenols. Cur. Pharm. Biotechnol., 2014, 15, 391-400.
4. Roselli, M.; Lentini, G.; Habtemariam, S. Phytochemical, antioxidant and anti-alpha-glucosidase activity evaluations of Bergenia cordifolia. Phytothe. Res., 2012, 26, 908-914.
5. Arjumand, W.; Seth, A.; Sultana, S. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats. Food Chem. Toxicol., 2011, 49(9), 2013-2021.
6. Han, Y. Rutin has therapeutic effect on septic arthritis caused by Candida albicans. Int. Immunopharmacol., 2009, 9(2), 207-211.
7. Lee, W.; Ku, S.K.; Bae, J.S. Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo. Food Chem. Toxicol., 2012, 50(9), 3048-3055.
8. Javed, H.; Khan, M.M.; Ahmad, A.; Vaibhav, K.; Ahmad, M.E.; Khan, A.; Ashafaq, M.; Islam, F.; Siddiqui, MS.; Safhi, MM.; Islam, F. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type. Neuroscience, 2012, 210, 340-352.
9. Pyrzanowska, J.; Piechal, A.; Blecharz-Klin, K.; Joniec-Maciejak, I.; Zobel, A.; Widy-Tyszkiewicz, E. Influence of long-term administration of rutin on spatial memory as well as the concentration of brain neurotransmitters in aged rats. Pharmacol. Rep., 2012, 64(4), 808-816.
10. Gao, M.; Ma, Y.; Liu, D. Rutin suppresses palmitic acids-triggered inflammation in macrophages and blocks high fat diet-induced obesity and fatty liver in mice. Pharm. Res., 2013, 30(11), 2940- 2950.
11. Chen, H.; Miao, Q.; Geng, M.; Liu, J.; Hu, Y.; Tian, L.; Pan, J.; Yang, Y. Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. Sci. World J., 2013, 2013, 269165.
12. Pan, P.H.; Lin, S.Y.; Wang, Y.Y.; Chen, W.Y.; Chuang, Y.H.; Wu, C.C.; Chen, C.J. Protective effects of rutin on liver injury induced by biliary obstruction in rats. Free Radic. Biol. Med., 2014, 73, 106-116.
13. Machawal, L.; Kumar, A. Possible involvement of nitric oxide mechanism in the neuroprotective effect of rutin against immobilization stress induced anxiety like behaviour, oxidative damage in mice. Pharmacol. Rep., 2014, 66(1), 15-21.
14. Magalingam, K.B.; Radhakrishnan, A.; Haleagrahara, N. Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int. J. Mol. Med., 2013, 32, 235-240.
15. Tongjaroenbuangam, W.; Ruksee, N.; Chantiratikul, P.; Pakdeenarong, N.; Kongbuntad, W.; Govitrapong, P. Neuroprotective effects of quercetin, rutin and okra (Abelmoschus esculentus Linn.) in dexamethasone-treated mice. Neurochem. Int., 2011, 59(5), 677-685.
16. Mondal, A.; Maity, T.K.; Pal, D. Hypoglycaemic effect of Melothria heterophylla in streptozotocin-induced diabetic rats. Pharm. Biol., 2012, 50(9), 1151-1156.
17. Rauter, A.P.; Martins, A.; Borges, C.; Mota-Filipe, H.; Pinto, R.; Sepodes, B.; Justino, J. Antihyperglycaemic and protective effects of flavonoids on streptozotocin-induced diabetic rats. Phytother Res., 2010, S2, S133-S138.
18. Kamalakkannan, N.; Stanely, M.P.P. The influence of rutin on the extracellular matrix in streptozotocin-induced diabetic rat kidney. J. Pharm. Pharmacol., 2006, 58(8), 1091-1098.
19. Stanely, M.P.P.; Kannan, N.K. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol., 2006, 58(10), 1373-1383.
20. Kamalakkannan, N.; Stanely M.P.P. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat tissues. Mol. Cell. Biochem., 2006, 293(1-2), 211-219.
21. Kamalakkannan, N.; Prince, P.S. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats. Basic. Clin. Pharmacol. Toxicol., 2006, 98(1), 97-03.
22. Krishna, K.M.; Annapurna, A.; Gopal, G.S.; Chalam, C.R.; Madan, K.; Kumar, V.K.; Prakash, G.J. Partial reversal by rutin and quercetin of impaired cardiac function in streptozotocin-induced diabetic rats. Can. J. Physiol. Pharmacol., 2005, 83(4), 343-355.
23. Fernandes, A.A.; Novelli, E.L.; Okoshi, K.; Okoshi, M.P.; Di Muzio, B.P.; Guimaraes, J.F.; Fernandes, Junior A. Influence of rutin treatment on biochemical alterations in experimental diabetes. Biomed. Pharmacother., 2010, 64(3), 214-219.
24. Hao, H.H.; Shao, Z.M.; Tang, D.Q.; Lu, Q.; Chen, X.; Yin, X.X.; Wu, J.; Chen, H. Preventive effects of rutin on the development of experimental diabetic nephropathy in rats. Life Sci., 2012, 91(19- 20), 959-967.
25. Hsu, C.Y.; Shih, H.Y.; Chia, Y.C.; Lee, C.H.; Ashida, H.; Lai, Y.K.; Weng, C.F. Rutin potentiates insulin receptor kinase to enhance insulin-dependent glucose transporter 4 translocation. Mol. Nutr. Food Res., 2014, 58(6), 1168-1176.
26. Hunyadi, A.; Martins, A.; Hsieh, T.J.; Seres, A.; Zupko, I. Chlorogenic acid and rutin play a major role in the in vivo antidiabetic activity of Morus alba leaf extract on type II diabetic rats. PLoS One, 2012, 7(11), e50619.
27. Habtemariam, S. α-Glucosidase inhibitory activity of kaempferol- 3-O-rutinoside. Nat. Prod. Commun., 2011, 6(2), 201-203.
28. Gao, H.; Huang, Y-N.; Xu, P-Y.; Inagaki, C.; Kawabata, J. α - Glucosidase inhibitory effect by the flower buds of Tussilago farfara L. Food Chem., 2008, 106(3), 1195-1201.
29. Li, Y.Q.; Zhou, F.C.; Gao, F.; Bian, J.S.; Shan, F. Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase. J. Agric. Food Chem., 2009, 57(24), 11463- 11468.
30. Pham, A.T.; Malterud, K.E.; Paulsen, B.S.; Diallo, D.; Wangensteen, H. α -Glucosidase inhibition, 15-lipoxygenase inhibition, and brine shrimp toxicity of extracts and isolated compounds from Terminalia macroptera leaves. Pharm. Biol., 2014, 52(9), 1166-1169.
31. Tundis, R.; Loizzo, M.R.; Menichini, F. Natural products as alphaamylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: An update. Mini. Rev. Med. Chem., 2010, 10(4), 315-331.
32. Kappel, V.D.; Zanatta, L.; Postal, BG.; Silva, F.R. Rutin potentiates calcium uptake via voltage-dependent calcium channel associated with stimulation of glucose uptake in skeletal muscle. Arch Biochem Biophys., 2013, 532(2), 55-60.
33. Kappel, V.D.; Cazarolli, L.H.; Pereira, D.F.; Postal, B.G.; Zamoner, A.; Reginatto, F.H.; Silva, F.R. Involvement of GLUT-4 in the stimulatory effect of rutin on glucose uptake in rat soleus muscle. J. Pharm. Pharmacol., 2013, 65(10), 1179-1186.
34. Lee, J.O.; Lee, S.K.; Kim, J.H.; Kim, N.; You, G.Y.; Moon, J.W.; Kim, S.J.; Park, S.H.; Kim, H.S. Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activatedprotein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells. J. Biol. Chem., 2012, 287(53), 44121-44129.
35. Dhanya, R.; Arun, K.B.; Syama, H.P.; Nisha, P.; Sundaresan, A.; Santhosh, K.T.R.; Jayamurthy, P. Rutin and quercetin enhance glucose uptake in L6 myotubes under oxidative stress induced by tertiary butyl hydrogen peroxide. Food Chem., 2014, 158, 546-554.
36. Cai, E.P.; Lin, J.K. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J. Agric. Food Chem., 2009, 57(20), 9817-9827.
37. Butler, A.E.; Janson, J.; Bonner-Weir, S.; Ritzel, R.; Rizza, R.A.; Butler, P.C. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 2003, 52(1), 102-110.
38. Cnop, M.; Welsh, N.; Jonas, J.C.; Jorns, A.; Lenzen, S.; Eizirik, D.L. (2005). Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes, 2005, 54S, S97-S107.
39. Muthenna, P.; Akileshwari, C.; Saraswat, M.; Bhanuprakash, R.G. Inhibition of advanced glycation end-product formation on eye lens protein by rutin. Br. J. Nutr., 2012, 107(7), 941-949.
40. Ghaffari, M.A.; Mojab, S. Influence of flavonols as in vitro on low density lipoprotein glycation. Iran Biomed. J., 2007, 11(3), 185- 191.
41. Urios, P.; Grigorova-Borsos, A.M.; Sternberg, M. Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure. Eur. J. Nutr. 2007, 46(3), 139-146.
42. Perry, R.J.; Samuel, V.T.; Petersen, K.F.; Shulman, G.I. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature, 2014, 510(7503), 84-91.
43. Hsu, C.L.; Yen, G.C. Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. J. Agric. Food. Chem., 2007, 55(21), 8404-8410.
44. Guan, Y-F.; Breyer, M.D. Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease. Kidney Int., 2001, 60(1), 14-30.
45. Wu, C.H.; Lin M.C.; Wang, H.C.; Yang, M.Y.; Jou, M.J.; Wang, C.J. Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells. J. Food Sci., 2011, 76(2), T65-72.
46. Zhang, X.; Song, J.; Shi, X.; Miao, S.; Li, Y.; Wen, A. Absorption and metabolism characteristics of rutin in Caco-2 cells. Sci. World J., 2013, 2013, 382350.
47. Carbonaro, M.; Grant, G. Absorption of quercetin and rutin in rat small intestine. Ann. Nutr. Metab., 2005, 49(3), 178-182.
48. Andlauer, W.; Stumpf, C.; Furst, P. Intestinal absorption of rutin in free and conjugated forms. Biochem. Pharmacol., 2001, 62(3), 369- 374.
49. Shimoi, K.; Yoshizumi, K.; Kido, T.; Usui, Y.; Yumoto, T. Absorption and urinary excretion of quercetin, rutin, and αG-rutin, a water soluble flavonoid, in rats. J. Agric. Food. Chem., 2003, 51(9), 2785- 2789.
50. Shetty, A.K.; Rashmi, R.; Rajan, M.G.R.; Sambaiah, K.; Salimath, P.V. Antidiabetic influence of quercetin in streptozotocininduced diabetic rats. Nut. Res., 2004, 24(5), 373-381.
51. Vessal, M.; Hemmati, M.; Vasei, M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C: Pharmacol. Toxicol., 2003, 135C(3), 357-364.
52. Fang, X-K.; Gao, J.; Zhu, D-N. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity. Life Sci., 2008, 82(11-12), 615-622.
53. Heilbronn, L.K.; Campbell, L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des., 2008, 14(12), 1225-1230.
54. Senn, J.J.; Klover, P.J.; Nowak, I.A.; Mooney, R.A. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes, 2002, 51(12), 3391-3399.
55. Shoelson, S.E.; Lee, J.; Goldfine, A.B. Inflammation and insulin resistance. J. Clin. Invest., 2006, 116(7),1793-1801.
56. Selloum, L.; Bouriche, H.; Tigrine, C.; Boudoukha, C. Antiinflammatory effect of rutin on rat paw oedema, and on neutrophils chemotaxis and degranulation. Exp. Toxicol. Pathol., 2003, 54(4), 313-318.
57. Chen, Y.S.; Hu, Q.H.; Zhang, X.; Zhu, Q.; Kong, L.D. Beneficial effect of rutin on oxonate-induced hyperuricemia and renal dysfunction in mice. Pharmacol., 2013, 92(1-2), 75-83.
58. Tang, D.Q.; Wei, Y.Q.; Gao, Y.Y.; Yin, X.X.; Yang, D.Z.; Mou, J.; Jiang X.L. Protective effects of rutin on rat glomerular mesangial cells cultured in high glucose conditions. Phytother. Res., 2011, 25(11), 1640-1647.
59. Sadeghnia, H.R.; Yousefsani, B.S.; Rashidfar, M.; Boroushaki, M.T.; Asadpour, E.; Ghorbani, A. Protective effect of rutin on hexachlorobutadiene-induced nephrotoxicity. Ren. Fail., 2013, 35(8), 1151-1155.
60. Korkmaz, A.; Kolankaya, D. Protective effect of rutin on the ischemia/reperfusion induced damage in rat kidney. J. Surg. Res., 2010, 164(2), 309-315.
61. Khan R.A.; Khan, M.R.; Sahreen, S. Protective effects of rutin against potassium bromate induced nephrotoxicity in rats. BMC Comp. Alt. Med., 2012, 12, 204.
62. Li, Q.; Niu, S.; Wang, R.; Li, Y.; Zhang, R.; Zhu, D. Mechanisms that underlie the induction of vasodilation in pulmonary artery by rutin. Int. Angiol., 2012, 31(6), 557-564.
63. Panchal, S.K.; Poudyal, H.; Arumugam, T.V.; Brown, L. Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J. Nutr., 2011, 141(6), 1062-1069.